MY8500791A - Hydrocortisone derivative - Google Patents

Hydrocortisone derivative

Info

Publication number: MY8500791A
Authority: MY; Malaysia
Prior art keywords: hydrocortisone derivative; hydrocortisone; derivative
Prior art date: 1978-03-29

Application number

MY791/85A

Other languages

English (en)

Inventor

Yasuhide Tachi

Kazuhiko Michishita

Jozi Nakagami

Jiro Sawada

Mitsunori Washitake

Yoshiaki Kamano

Original Assignee

Taisho Pharmaceutical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1978-03-29

Filing date

1985-12-30

Publication date

1985-12-31

1985-12-30 Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd

1985-12-31 Publication of MY8500791A publication Critical patent/MY8500791A/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Endocrinology (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Engineering & Computer Science (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)

MY791/85A 1978-03-29 1985-12-30 Hydrocortisone derivative MY8500791A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP53036251A JPS6040439B2 (ja)	1978-03-29	1978-03-29	ヒドロコルチゾン誘導体

Publications (1)

Publication Number	Publication Date
MY8500791A true MY8500791A (en)	1985-12-31

Family

ID=12464544

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MY791/85A MY8500791A (en)	1978-03-29	1985-12-30	Hydrocortisone derivative

Country Status (11)

Country	Link
US (1)	US4290962A (de)
JP (1)	JPS6040439B2 (de)
AR (1)	AR221717A1 (de)
CH (1)	CH638227A5 (de)
DE (1)	DE2910899C2 (de)
FR (1)	FR2421180A1 (de)
GB (1)	GB2020291B (de)
IT (1)	IT1116531B (de)
KE (1)	KE3481A (de)
MY (1)	MY8500791A (de)
SG (1)	SG55584G (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2826257C3 (de) *	1978-06-15	1980-12-04	Beiersdorf Ag, 2000 Hamburg	Hydrocortison-17,21-diester und Verfahren zu deren Herstellung, diese enthaltende Arzneimittel sowie Hydrocortison -17-propionat als Zwischenprodukt
ATE12237T1 (de) *	1980-12-23	1985-04-15	Schering Ag	Neue 6-alpha-methylhydrocortison-derivate, ihre herstellung und verwendung.
DE3133082A1 (de)	1981-08-18	1983-03-10	Schering Ag, 1000 Berlin Und 4619 Bergkamen	Neue hydrocortison-derivate, ihre herstellung und verwendung
DE3133081A1 (de) *	1981-08-18	1983-03-10	Schering Ag, 1000 Berlin Und 4619 Bergkamen	Neue 6(alpha)-methylprednisolon-derivate, ihre herstellung und verwendung
JPS59137408A (ja) *	1983-01-27	1984-08-07	Taisho Pharmaceut Co Ltd	軟膏
AT389447B (de) *	1983-01-27	1989-12-11	Taisho Pharmaceutical Co Ltd	Verfahren zur herstellung einer topischen steroidsalbe
JPS59139315A (ja) *	1983-01-31	1984-08-10	Taisho Pharmaceut Co Ltd	クリ−ム剤
US8790637B2 (en)	2003-06-27	2014-07-29	DePuy Synthes Products, LLC	Repair and regeneration of ocular tissue using postpartum-derived cells
WO2005001079A2 (en)	2003-06-27	2005-01-06	Ethicon, Incorporated	Soft tissue repair and regeneration using postpartum-derived cells
US9592258B2 (en)	2003-06-27	2017-03-14	DePuy Synthes Products, Inc.	Treatment of neurological injury by administration of human umbilical cord tissue-derived cells
US9572840B2 (en)	2003-06-27	2017-02-21	DePuy Synthes Products, Inc.	Regeneration and repair of neural tissue using postpartum-derived cells
US7825147B2 (en) *	2003-08-29	2010-11-02	Ranbaxy Laboratories Limited	Inhibitors of phosphodiesterase type-IV
US20070259874A1 (en) *	2003-11-26	2007-11-08	Palle Venkata P	Phosphodiesterase Inhibitors
PL1831356T3 (pl)	2004-12-23	2017-07-31	DePuy Synthes Products, Inc.	Komórki poporodowe pochodzące z tkanki pępowinowej i sposoby ich wytwarzania i stosowania
US7915286B2 (en)	2005-09-16	2011-03-29	Ranbaxy Laboratories Limited	Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
WO2007045979A1 (en)	2005-10-19	2007-04-26	Ranbaxy Laboratories Limited	Pharmaceutical compositions of muscarinic receptor antagonists
BRPI0617673C1 (pt) *	2005-10-19	2012-05-22	Ranbaxy Lab Ltd	composições de inibidores de fosfodiesterase do tipo iv
ES2642844T3 (es)	2005-12-16	2017-11-20	DePuy Synthes Products, Inc.	Composiciones y métodos para inhibir una respuesta inmune adversa en el trasplante de histocompatibilidad que no coinciden
US9125906B2 (en)	2005-12-28	2015-09-08	DePuy Synthes Products, Inc.	Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
WO2008035315A2 (en) *	2006-09-22	2008-03-27	Ranbaxy Laboratories Limited	Inhibitors of phosphodiesterase type-iv
EP2066661A2 (de) *	2006-09-22	2009-06-10	Ranbaxy Laboratories Limited	Phosphodiesteraseinhibitoren
EP2089511B1 (de)	2006-11-13	2014-09-17	DePuy Synthes Products, LLC	In-vitro-expansion von postpartalen zellen mittels mikroträgern
EP1958947A1 (de)	2007-02-15	2008-08-20	Ranbaxy Laboratories Limited	Inhibitoren für Phosphodiesterase Typ 4
US20110130403A1 (en) *	2007-03-14	2011-06-02	Ranbaxy Laboratories Limited	Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
DK2124944T3 (da)	2007-03-14	2012-04-23	Ranbaxy Lab Ltd	Pyrazolo[3,4-b]pyridinderivater som phosphodiesteraseinhibitorer
ITMI20071616A1 (it)	2007-08-03	2009-02-04	Cosmo Spa	Processo enzimatico per l'ottenimento di 17-alfa monoesteri del cortexolone e/o suoi 9,11-deidroderivati.
EP2111861A1 (de)	2008-04-21	2009-10-28	Ranbaxy Laboratories Limited	Zusammensetzungen von Phosphodiesterase-IV-Hemmern
CN107028983A (zh) *	2008-12-19	2017-08-11	德普伊新特斯产品有限责任公司	肺部疾病和病症的治疗
US10179900B2 (en)	2008-12-19	2019-01-15	DePuy Synthes Products, Inc.	Conditioned media and methods of making a conditioned media
CN104356188A (zh) *	2014-10-23	2015-02-18	华中药业股份有限公司	一种丁酸氢化可的松的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1195748B (de) *	1961-06-24	1965-07-01	Vismara Francesco Spa	Verfahren zur Herstellung von 1'-substituierten 17alpha, 21-(1'-Alkoxy)-methylendioxysterioden
GB1043347A (en) *	1963-05-10	1966-09-21	Glaxo Lab Ltd	17,21-orthoesters of steroids
GB1047518A (en) *	1963-06-11	1966-11-02	Glaxo Lab Ltd	17ª-monoesters of 11,17,21-trihydroxy steroid compounds
US3422193A (en) *	1966-08-11	1969-01-14	Schering Corp	17-mono esters of corticoids
DE2144405A1 (de) *	1971-09-04	1973-03-08	Merck Patent Gmbh	Verfahren zur herstellung von estern der pregnanreihe
DE2826257C3 (de) *	1978-06-15	1980-12-04	Beiersdorf Ag, 2000 Hamburg	Hydrocortison-17,21-diester und Verfahren zu deren Herstellung, diese enthaltende Arzneimittel sowie Hydrocortison -17-propionat als Zwischenprodukt

1978
- 1978-03-29 JP JP53036251A patent/JPS6040439B2/ja not_active Expired
1979
- 1979-03-08 GB GB7908189A patent/GB2020291B/en not_active Expired
- 1979-03-14 AR AR275802A patent/AR221717A1/es active
- 1979-03-20 DE DE2910899A patent/DE2910899C2/de not_active Expired
- 1979-03-26 US US06/024,111 patent/US4290962A/en not_active Expired - Lifetime
- 1979-03-27 IT IT48501/79A patent/IT1116531B/it active
- 1979-03-28 FR FR7907832A patent/FR2421180A1/fr active Granted
- 1979-03-28 CH CH286179A patent/CH638227A5/fr not_active IP Right Cessation
1984
- 1984-08-07 SG SG555/84A patent/SG55584G/en unknown
- 1984-12-07 KE KE3481A patent/KE3481A/xx unknown
1985
- 1985-12-30 MY MY791/85A patent/MY8500791A/xx unknown

Also Published As

Publication number	Publication date
US4290962A (en)	1981-09-22
KE3481A (en)	1985-01-04
GB2020291A (en)	1979-11-14
DE2910899A1 (de)	1979-10-11
IT1116531B (it)	1986-02-10
FR2421180A1 (fr)	1979-10-26
FR2421180B1 (de)	1982-10-22
SG55584G (en)	1985-03-08
CH638227A5 (fr)	1983-09-15
JPS54128560A (en)	1979-10-05
JPS6040439B2 (ja)	1985-09-11
DE2910899C2 (de)	1986-02-13
IT7948501A0 (it)	1979-03-27
AR221717A1 (es)	1981-03-13
GB2020291B (en)	1982-10-06

Publication	Publication Date	Title
SG55584G (en)	1985-03-08	Hydrocortisone derivative
JPS54109975A (en)	1979-08-29	Thienohydantoin derivative
JPS54141798A (en)	1979-11-05	44desacetyl vlboo33carboxyhydrazide derivative
JPS54119450A (en)	1979-09-17	2hhbenzofurann33one derivative
JPS54132627A (en)	1979-10-15	Cumalin derivative
JPS5527193A (en)	1980-02-27	Spiroofuranohydantoin derivative
GB2022079B (en)	1982-11-17	L-leucyl-4-hydroxyanilide derivatives
JPS54151966A (en)	1979-11-29	Nnsubstituted oxobenzothiazoline derivative
GB2018757B (en)	1982-09-02	3-phenyltetrahydropyridine derivatives
PH17055A (en)	1984-05-17	Delta4-androstenes derivative
GB2017708B (en)	1982-10-27	Steroid-spirooxazolidinone derivatives
JPS54128573A (en)	1979-10-05	Cholestane derivative
JPS54128570A (en)	1979-10-05	Arylaminoimidazoline derivative
GB2019843B (en)	1982-08-04	N-alkenylmoranoline derivatives
GB2017691B (en)	1982-06-16	2-hydroxymethyl-pyrazine derivatives
JPS5543080A (en)	1980-03-26	22oxazolin derivative
GB2024806B (en)	1982-05-06	Onomycin derivatives
JPS54163596A (en)	1979-12-26	Flonaphlizine derivative
JPS54109991A (en)	1979-08-29	111alkanoyll4*deoxyy4*isonitroooleandomycin derivative
GB2023574B (en)	1982-11-24	N-cyano-azomethine derivatives
GB2013187B (en)	1982-06-03	Phenylpyrol derivatives
JPS5581835A (en)	1980-06-20	Novel pentenee22yl derivative
JPS557262A (en)	1980-01-19	Novel bettaine derivative
JPS54122232A (en)	1979-09-21	Phenylnitramine derivative
JPS54154775A (en)	1979-12-06	Benzylpyrimidine derivative